These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 28329051)
21. Origin of acetylcholinesterase in the neuromuscular junction formed in the in vitro innervated human muscle. Jevsek M; Mars T; Mis K; Grubic Z Eur J Neurosci; 2004 Dec; 20(11):2865-71. PubMed ID: 15579140 [TBL] [Abstract][Full Text] [Related]
22. Milk fat globule membrane supplementation with voluntary running exercise attenuates age-related motor dysfunction by suppressing neuromuscular junction abnormalities in mice. Yano M; Minegishi Y; Sugita S; Ota N Exp Gerontol; 2017 Oct; 97():29-37. PubMed ID: 28729214 [TBL] [Abstract][Full Text] [Related]
23. Older mice show decreased regeneration of neuromuscular junctions following lengthening contraction-induced injury. Paul TA; Macpherson PC; Janetzke TL; Davis CS; Jackson MJ; McArdle A; Brooks SV Geroscience; 2023 Jun; 45(3):1899-1912. PubMed ID: 36952126 [TBL] [Abstract][Full Text] [Related]
24. Impact of Aging on Proprioceptive Sensory Neurons and Intrafusal Muscle Fibers in Mice. Vaughan SK; Stanley OL; Valdez G J Gerontol A Biol Sci Med Sci; 2017 Jun; 72(6):771-779. PubMed ID: 27688482 [TBL] [Abstract][Full Text] [Related]
26. Presynaptic to postsynaptic relationships of the neuromuscular junction are held constant across age and muscle fiber type. Deschenes MR; Hurst TE; Ramser AE; Sherman EG Dev Neurobiol; 2013 Oct; 73(10):744-53. PubMed ID: 23696094 [TBL] [Abstract][Full Text] [Related]
27. Degeneration and regeneration of neuromuscular junction architecture in rat skeletal muscle fibers damaged by bupivacaine hydrochloride. Nishizawa T; Tamaki H; Kasuga N; Takekura H J Muscle Res Cell Motil; 2003; 24(8):527-37. PubMed ID: 14870968 [TBL] [Abstract][Full Text] [Related]
28. Abnormalities in neuromuscular junction structure and skeletal muscle function in mice lacking the P2X2 nucleotide receptor. Ryten M; Koshi R; Knight GE; Turmaine M; Dunn P; Cockayne DA; Ford AP; Burnstock G Neuroscience; 2007 Sep; 148(3):700-11. PubMed ID: 17706883 [TBL] [Abstract][Full Text] [Related]
29. Participation of myosin Va and Pka type I in the regeneration of neuromuscular junctions. Röder IV; Strack S; Reischl M; Dahley O; Khan MM; Kassel O; Zaccolo M; Rudolf R PLoS One; 2012; 7(7):e40860. PubMed ID: 22815846 [TBL] [Abstract][Full Text] [Related]
30. Is dystrophin present in the nerve terminal at the neuromuscular junction? An immunohistochemical study of the heterozygote dystrophic (mdx) mouse. Huard J; Fortier LP; Labrecque C; Dansereau G; Tremblay JP Synapse; 1991 Feb; 7(2):135-40. PubMed ID: 2011828 [TBL] [Abstract][Full Text] [Related]
31. Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions. Bolatto C; Olivera-Bravo S; Cerri S J Vis Exp; 2021 Aug; (174):. PubMed ID: 34459813 [TBL] [Abstract][Full Text] [Related]
32. LAP proteins are localized at the post-synaptic membrane of neuromuscular junctions and appear to modulate synaptic morphology and transmission. Kravic B; Huraskin D; Frick AD; Jung J; Redai V; Palmisano R; Marchetto S; Borg JP; Mei L; Hashemolhosseini S J Neurochem; 2016 Nov; 139(3):381-395. PubMed ID: 27321929 [TBL] [Abstract][Full Text] [Related]
34. Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins. Shiao T; Fond A; Deng B; Wehling-Henricks M; Adams ME; Froehner SC; Tidball JG Hum Mol Genet; 2004 Sep; 13(17):1873-84. PubMed ID: 15238508 [TBL] [Abstract][Full Text] [Related]
35. Using PDE inhibitors to harness the benefits of calorie restriction: lessons from resveratrol. Chung JH Aging (Albany NY); 2012 Mar; 4(3):144-5. PubMed ID: 22388573 [TBL] [Abstract][Full Text] [Related]
36. The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. De Winter F; Vo T; Stam FJ; Wisman LA; Bär PR; Niclou SP; van Muiswinkel FL; Verhaagen J Mol Cell Neurosci; 2006; 32(1-2):102-17. PubMed ID: 16677822 [TBL] [Abstract][Full Text] [Related]
37. Cellular and Molecular Anatomy of the Human Neuromuscular Junction. Jones RA; Harrison C; Eaton SL; Llavero Hurtado M; Graham LC; Alkhammash L; Oladiran OA; Gale A; Lamont DJ; Simpson H; Simmen MW; Soeller C; Wishart TM; Gillingwater TH Cell Rep; 2017 Nov; 21(9):2348-2356. PubMed ID: 29186674 [TBL] [Abstract][Full Text] [Related]
38. MHCI promotes developmental synapse elimination and aging-related synapse loss at the vertebrate neuromuscular junction. Tetruashvily MM; McDonald MA; Frietze KK; Boulanger LM Brain Behav Immun; 2016 Aug; 56():197-208. PubMed ID: 26802986 [TBL] [Abstract][Full Text] [Related]
39. Disuse and functional overload induced by tooth extraction alters neuromuscular morphology in C57BL/6J mice. Fahim MA; El Kerdany MK Cell Mol Biol (Noisy-le-grand); 1999 Jun; 45(4):401-5. PubMed ID: 10432186 [TBL] [Abstract][Full Text] [Related]
40. Human neuromuscular junction three-dimensional organoid models and the insight in motor disorders. Zhang K; Bai L; Xu W; Shen C J Mol Cell Biol; 2022 Jan; 13(11):767-773. PubMed ID: 34270721 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]